Navigation Links
PathoGenetix Hires Food Safety Testing Expert John W. Czajka as Vice President of Business Development
Date:12/12/2012

Woburn, MA (PRWEB) December 12, 2012

PathoGenetix, Inc., a commercial-stage developer of an automated system for rapid identification and typing of bacteria strains, today announced that John W. Czajka, Ph.D., M.B.A. has joined the company as Vice President of Business Development. Dr. Czajka will coordinate the commercial application of the company’s proprietary Genome Sequence Scanning™ (GSS™) technology for food safety testing and outbreak investigation. The automated benchtop GSS system will identify foodborne pathogens to strain level, directly from complex mixtures such as food and clinical enrichment cultures, in four hours.

Dr. Czajka has more than 15 years of experience in the field of molecular diagnostics, with expertise in foodborne pathogen and biowarfare threat identification, as well as veterinary and human clinical diagnostics. He joins PathoGenetix after nine years of progressive leadership positions at Smiths Detection as a research scientist, R&D Program Manager, Vice President of Technology Assessment and Acquisition, and Director of Business Development for Smiths Detection Diagnostics. Prior to Smiths Detection, Dr. Czajka developed PCR assays and molecular typing technologies for foodborne pathogens with DuPont Qualicon. Dr. Czajka holds a Ph.D. from Cornell University, Department of Food Science with a focus on foodborne pathogen detection and molecular diagnostics, and an M.B.A. in Technology Management from the University of Phoenix.

“John’s successful track record in the development of new technologies and products is a perfect match for PathoGenetix as we seek to bring our innovative bacterial identification technology to the food safety market,” said Ann Merrifield, President and CEO of PathoGenetix.

Food companies and government agencies conduct regular food safety testing on raw materials, production facilities and finished products, to ensure food quality and detect potentially dangerous organisms like Salmonella, Listeria or E. coli in food imports and food products. At the same time, government agencies and public health labs track pathogens that are making people sick during outbreaks. When a pathogen is detected in a food production facility, or is affecting people in multiple locations or states, an investigation is undertaken to identify the organism and trace it back to its source.

Current microbial typing systems require time-consuming sample preparation to culture and isolate bacteria, followed by complex protocols that often produce inconsistent results even when run by the most skilled operators. Genome Sequence Scanning is a breakthrough in rapid bacterial identification and typing that offers new levels of speed, automation and accuracy for food safety testing and public health investigations of foodborne pathogen outbreaks. Because GSS works directly from complex samples, it can provide strain-level identification in just four hours, days sooner than other methods.

“PathoGenetix’s Genome Sequence Scanning is a breakthrough identification technology for food companies and government agencies working to ensure food safety,” said Dr. Czajka. “Rapid, accurate and cost-effective identification and strain typing of foodborne pathogens allows for better source tracking and faster outbreak investigations, and that means safer food, fewer foodborne illnesses, and subsequently fewer deaths.”

Genome Sequence Scanning utilizes an automated system that extracts and analyzes microbial DNA from enriched food or clinical samples to confirm and characterize foodborne pathogens. The strain information provided is comparable to pulsed field gel electrophoresis (PFGE), the current gold standard for food pathogen typing in outbreak investigations. Yet, because GSS does not require a cultured isolate, it is compatible with sample preparation protocols that are often used with the newer, rapid detection methods that are increasingly in use in clinical and food safety testing laboratories. Its automated platform and simplified protocol require minimal training and ensure consistent, accurate results.

About PathoGenetix, Inc.
PathoGenetix, Inc., is a commercial-stage developer of a rapid, single-molecule analysis technology for bacterial strain typing and identification. Proprietary Genome Sequence Scanning™ (GSS™) is a breakthrough in microbial identification that works directly from complex samples and provides results in just four hours—days faster than current microbiological identification methods. The simplified protocol and automated platform require minimal training and ensure consistent results. PathoGenetix is currently developing a compact, benchtop GSS system for use in food safety testing and outbreak investigation, which will be available in 2013. Learn more at http://www.pathogenetix.com

Read the full story at http://www.prweb.com/releases/food_safety_testing/bacterial_identification/prweb10227334.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. PathoGenetix Names Ann Merrifield as Chief Executive Officer and Prepares to Launch Unique Bacterial Identification Technology
2. Zyngenia, Inc. Promotes Chief Scientific Officer and Hires Chief Business Officer
3. Synthetic Genomics Inc. Hires Industry Leader George E. Stagnitti to Head Food and Nutritional Products Development Program
4. Textile Company PurThread Technologies Opens Headquarters in Durham, North Carolina and Hires New Senior Staff
5. Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
6. Ernst & Young LLP Bolsters Fraud Investigation & Dispute Services with New Hires and Promotions
7. Provia Labs Hires Vice President of International Business Development to Expand Global Distribution for its Stem Cell Banking Service and Biobanking Products
8. Ganeden Biotech Hires New Marketing Manager
9. Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim)
10. New measuring techniques can improve efficiency, safety of nanoparticles
11. Interim Clinical Trial Results Confirm Safety of Renadyl™, a Probiotic Dietary Supplement for the Support of Healthy Kidney Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) ("RepliCel" or the ... from its phase 1/2 tendon repair study investigating the use ... a treatment for Achilles tendinosis. ... The clinical trial met its ... and showed no serious adverse events related to the study ...
(Date:3/27/2017)... , March 27, 2017 Cousins Properties (NYSE: ... world,s leading biotechnology companies, has signed a 10-year, approximately 125,000 ... A office asset located in the Westshore submarket of ... thrilled that Amgen has chosen Corporate Center for their new ... Gellerstedt , president and chief executive officer of Cousins Properties. ...
(Date:3/27/2017)... The new research portal will give ... reports on Valero Energy , offering extensive market research ... ... (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO) The latest trend gaining ... Ethanol today, even though touted as a green alternative to ...
(Date:3/27/2017)... , March 27, 2017 Neurotrope, ... novel therapies for neurodegenerative diseases, including Alzheimer,s disease, ... its application to list the Company,s common stock ... by The NASDAQ Stock Market, a unit of ... listing, Neurotrope will ring the Opening Bell at the ...
Breaking Biology Technology:
(Date:3/6/2017)... March 6, 2017 Mintigo , ... today announced Predictive Sales Coach TM , its ... sales intelligence into Salesforce. This unique AI application ... sales organizations with deep knowledge of their customers ... intelligent engagement. Predictive Sales Coach extends Mintigo,s existing ...
(Date:3/2/2017)... 2, 2017 Who risk to be deprived ... the full report: https://www.reportbuyer.com/product/4313699/ WILL APPLE ... FIELD? Fingerprint sensors using capacitive technology represent a ... vendor Idex forecasts an increase of 360% of the ... of the fingerprint sensor market between 2014 and 2017 ...
(Date:2/28/2017)... Feb. 28, 2017   Acuant , a leading ... announces significant enhancements to new and core technologies building ... products include mobile and desktop Acuant FRM TM ... - a real time manual review of identity documents ... provides the fastest and most accurate capture software to ...
Breaking Biology News(10 mins):